# Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)

> **NCT00686894** · PHASE4 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 7 (actual)

## Conditions studied

- Spondylitis, Ankylosing
- SpA

## Interventions

- **PROCEDURE:** PDUS
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00686894
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Poor Enrollment
- **Last updated:** 2017-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686894, "Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00686894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*